Use of aerosolized levofloxacin for treating cystic fibrosis

Details for Australian Patent Application No. 2010289326 (hide)

Owner MPex Pharmaceuticals, Inc.

Inventors Loutit, Jefferey S.; Morgan, Elizabeth E.; Dudley, Michael N.; Griffith, David C.; Lomovskaya, Olga

Agent Shelston IP

Pub. Number AU-A-2010289326

PCT Pub. Number WO2011/029059

Priority 61/249,231 06.10.09 US; 61/240,092 04.09.09 US

Filing date 3 September 2010

Wipo publication date 10 March 2011

International Classifications

A61K 31/5383 (2006.01)

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 33/06 (2006.01) Medicinal preparations containing inorganic active ingredients - Aluminium, calcium or magnesium

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

22 March 2012 PCT application entered the National Phase

  PCT publication WO2011/029059 Priority application(s): WO2011/029059

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010289333-Seed treatment compositions & methods

2010289325-Methods and systems for making electrodes having at least one functional gradient therein and devices resulting therefrom